Skip to content

EndoRings Colonoscopy for Adenoma Detection

EndoRings Versus Standard Colonoscopy for Adenoma Detection

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03469622
Acronym
ER
Enrollment
225
Registered
2018-03-19
Start date
2018-03-27
Completion date
2019-12-31
Last updated
2019-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma

Keywords

Adenoma, Polyp, EndoRings, Colonoscopy, Endoscopic device, Colon cancer screening

Brief summary

Adenoma detection rate (ADR) in colon cancer screening is most important for avoiding colon cancer development. Recent studies suggest a benefit of endoscopic devices attached to the distal tip of the colonoscope for improving the ADR. This work is the first GERMAN randomized controlled trial comparing standard colonoscopy with EndoRIngs-assisted colonoscopy. EndoRings is a new FDA approved device that is attached to the distal tip of the colonoscope. Better Polyp detection is suspected by flattening the mucosal folds during withdrawal

Interventions

DEVICEEndoRings

EndoRings-assisted colonoscopy

DEVICEStandard colonoscopy

Standard colonoscopy without any additional devices

Sponsors

Helios Albert-Schweitzer-Klinik Northeim
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* indication for colonoscopy (screening, surveillance, diagnostic) * age ≥ 45 years * ability to give informed consent

Exclusion criteria

* pregnancy * age \<45 years * known colonic strictures * chronic inflammatory bowel disease * active inflammation * s/p colonic resection * bleeding disorder

Design outcomes

Primary

MeasureTime frame
Adenoma detection rateduring colonoscopy

Countries

Germany

Contacts

Primary ContactTobias Meister, Prof. Dr.
tobias.meister@helios-gesundheit.de+495551971244

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026